Anumana, Inc., a leader in cardiovascular AI, today announced U.S. Food and Drug Administration (FDA) clearance of its ECG-AI (TM) algorithm for cardiac amyloidosis (CA) -- the first and only cleared ...
Implicity, a leader in remote patient monitoring and cardiac data management solutions, today revealed new research presented at the 2026 European Heart Rhythm Association Congress (EHRA) examining ...
Artificial intelligence (AI)-based algorithms that use electrocardiogram (ECG) data have high accuracy in predicting ST-elevation myocardial infarction (STEMI), according to study ...
Cedars-Sinai Health Sciences University investigators and colleagues created an algorithm designed to use data on sudden ...
A quick heart trace taken during a warm-up trot could identify racehorses at risk of cardiac arrhythmias during ...
The wearable ECG monitors market is witnessing significant growth, poised to expand from $4.78 billion in 2025 to $5.9 billion in 2026, at a compound annu ...
Researchers at Mount Sinai have created an analytic tool using machine learning that they say can predict cardiovascular disease risk in millions of patients with obstructive sleep apnea, according to ...
The announcement outlines a strategic collaboration between HeartBeam and Mount Sinai to develop and validate AI-based ECG Algorithms The collaboration is focused on building next-generation, ...
Southlake, Texas, March 16, 2026 (GLOBE NEWSWIRE)-- HeartSciences Inc. (Nasdaq: HSCS; HSCSW) ("HeartSciences” or the "Company”), a healthcare information ...
Artificial intelligence (AI)-based ECG interpretation outperformed standard pathways for the detection of occlusive myocardial infarction (MI), according to a study presented today at ESC Acute ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results